Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Oxidative stress injury in doxorubicin-induced cardiotoxicity
Songbo Mei, Lang Hong, Xinyong Cai, et al.
Toxicology Letters (2019) Vol. 307, pp. 41-48
Closed Access | Times Cited: 452

Showing 1-25 of 452 citing articles:

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 308
New insights into the activities and toxicities of the old anticancer drug doxorubicin
Sabina Y. van der Zanden, Xiaohang Qiao, Jacques Neefjes
FEBS Journal (2020) Vol. 288, Iss. 21, pp. 6095-6111
Open Access | Times Cited: 283
Amino acid metabolism in health and disease
Zhenan Ling, Yifan Jiang, Jun-Nan Ru, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 201
Oxidative Stress and Antioxidant Treatments in Cardiovascular Diseases
Wenjun Wang, Peter M. Kang
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1292-1292
Open Access | Times Cited: 147
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
Bin Bin Wu, Kam Tong Leung, Ellen Poon
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1912-1912
Open Access | Times Cited: 127
Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation
Qijing Wu, Wei Li, Jing Zhao, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111308-111308
Open Access | Times Cited: 125
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 102
Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy
Renye Yue, Cheng Zhang, Li Xu, et al.
Chem (2022) Vol. 8, Iss. 7, pp. 1956-1981
Open Access | Times Cited: 99
The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
Rony Abdi Syahputra, Urip Harahap, Aminah Dalimunthe, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 87
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 45
The interplay between PEGylated nanoparticles and blood immune system
Guo Chen, Haoyang Yuan, Yuxiu Wang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115044-115044
Closed Access | Times Cited: 44
Research Progress of Disulfide Bond Based Tumor Microenvironment Targeted Drug Delivery System
Weiran Ma, Xiaoying Wang, Dongqi Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 7547-7566
Open Access | Times Cited: 20
DOXORUBICIN-RELATED CARDIOTOXICITY: REVIEW OF FUNDAMENTAL PATHWAYS OF CARDIOVASCULAR SYSTEM INJURY
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Cardiovascular Pathology (2024) Vol. 73, pp. 107683-107683
Closed Access | Times Cited: 17
Metformin Alleviates Doxorubicin-Induced Cardiotoxicity via Preserving Mitochondrial Dynamics Balance and Calcium Homeostasis
Nashwa Maghraby, Mona A.H. El-Baz, A. Hassan, et al.
Applied Biochemistry and Biotechnology (2025)
Open Access | Times Cited: 3
Doxorubicin-loaded nanoscale metal–organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy
Ting Xue, Caina Xu, Yu Wang, et al.
Biomaterials Science (2019) Vol. 7, Iss. 11, pp. 4615-4623
Closed Access | Times Cited: 129
Aptamers used for biosensors and targeted therapy
Yi Ning, Jue Hu, Fangguo Lu
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110902-110902
Open Access | Times Cited: 121
Nanoscale covalent organic frameworks as theranostic platforms for oncotherapy: synthesis, functionalization, and applications
Qun Guan, Guang-Bo Wang, Lele Zhou, et al.
Nanoscale Advances (2020) Vol. 2, Iss. 9, pp. 3656-3733
Open Access | Times Cited: 119
pH-Responsive Polymer-Stabilized ZIF-8 Nanocomposites for Fluorescence and Magnetic Resonance Dual-Modal Imaging-Guided Chemo-/Photodynamic Combinational Cancer Therapy
Yating Qin, Hui Peng, Xi-Wen He, et al.
ACS Applied Materials & Interfaces (2019) Vol. 11, Iss. 37, pp. 34268-34281
Closed Access | Times Cited: 106
Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity
Shanshan Wei, Wanjun Ma, Xiaohui Li, et al.
Cardiovascular Toxicology (2020) Vol. 20, Iss. 5, pp. 507-519
Closed Access | Times Cited: 88
Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway
Lei Sun, Hua Wang, Dan Xu, et al.
Bioengineered (2021) Vol. 13, Iss. 1, pp. 48-60
Open Access | Times Cited: 87
Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes
Xiaoxue Yu, Yang Ruan, Xiuqing Huang, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 523, Iss. 1, pp. 140-146
Closed Access | Times Cited: 82
Microneedles for gene and drug delivery in skin cancer therapy
Defu Zhi, Ting Yang, Tingyu Zhang, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 158-177
Closed Access | Times Cited: 79
Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Bartosz Walkowski, Marcin Kleibert, Miłosz Majka, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1553-1553
Open Access | Times Cited: 66
Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways
Jie Wang, Jingjing Zhang, Mengjie Xiao, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 7, pp. 3105-3125
Closed Access | Times Cited: 64
Role of Calixarene in Chemotherapy Delivery Strategies
Rossella Basilotta, Deborah Mannino, Alessia Filippone, et al.
Molecules (2021) Vol. 26, Iss. 13, pp. 3963-3963
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top